Month: September 2019

The Long-Range Effects on Locally Important Marine Resources

Kotzebue, Alaska, a tiny city perched on the Baldwin Peninsula, is thirty-three miles above the Arctic Circle. Kotzebue is bordered by the Kotzebue Sound to the west and the Hotham Sound to the east. These two bodies of water both join into the Chucki Sea.

Methods of Reusing Food Waste

The development of an algorithm through the assessment of nutrients in a recycled food supplement for canines.

Protein Oxidation Implicated as the Primary Determinant of Bacterial Radioresistance

The amount of DNA damage caused by a given dose of γ-radiation for resistant and sensitive bacteria is very similar. Yet, the range of ionizing radiation (IR) resistances is large, with a factor of 200 separating the most-resistant from the most-sensitive species. For example, Deinococcus radiodurans can survive levels of IR (10 kGy) that induce approximately 100 DNA double-strand breaks (DSBs) per genome, whereas Shewanella oneidensis is killed by levels of IR (0.07 kGy) that result in less than 1 DSB per genome.

An Estimate of the Total DNA in the Biosphere

Although prokaryotes evolved at least 3 billion years before plants and animals, we find that the information content of prokaryotes is similar to plants and animals at the present day. This information-based approach offers a new way to quantify anthropogenic and natural processes in the biosphere and its information diversity over time.

How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review

Policymakers and regulators in the United States (US) and the European Union (EU) are weighing reforms to their medical device approval and post-market surveillance systems. Data may be available that identify strengths and weakness of the approaches to medical device regulation in these settings.

p53 Gene Repair with Zinc Finger Nucleases Optimised by Yeast 1-Hybrid and Validated by Solexa Sequencing

The tumor suppressor p53 serves as a “guardian of the genome” [1] and has been studied intensively for over 30 years. By responding to cellular stresses, such as DNA damage, hypoxia and cell-cycle aberrations, p53 is activated as a transcription factor. p53 can thus help to promote the repair and survival of damaged cells by inducing cell-cycle arrest, or it can promote the permanent removal of damaged cells by inducing programmed cell death or senescence

Neuroaesthetics and the Trouble with Beauty

The famous nineteenth-century psychophysicist Gustav Fechner was also a poet and art critic. Armed with the tools of science, Fechner sought to reconcile his various interests. He would doubtless be interested by technological developments in neuroscience that have revealed the operations of neurons at cellular resolution and have enabled us to peer almost unnoticed into each other’s working brains.

How Bitter Medicine Could Clear Up Asthma

Airway obstructive diseases, such as asthma and chronic obstructive pulmonary disease, cause the airways to narrow and make it difficult to breathe. Broncodilators are used to treat these conditions, but they often don’t work in severe cases and can cause serious side effects, such as abnormal heart rhythms and increased blood pressure.

RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design

Computational protein design tools to date have been useful for engineering proteins with a wide range of functions, including DNA binding, co-factor binding, catalysis, fluorescence spectral change, peptide-protein specificity, and protein-protein interaction. In building nanostructures, computational protein design methods have been applied to designing hyperthermophilic proteins, metalloproteins, water-soluble membrane channels, and higher order macromolecular assemblies. Many of these successes rely on fixed backbone approaches that maintain the backbone conformations seen in the original high-resolution crystal structures and focus on remodeling only the sidechains.

Multidrug-Resistant Gonorrhea: A Research and Development Roadmap to Discover New Medicines

Gonorrhea is among the most common sexually transmitted infections (STIs), with an estimated 78 million new cases in 2012 [1]. Countries with good surveillance have reported increases in cases of gonorrhea, such as an 11% rise between 2014 and 2015 in the United Kingdom [2], a doubling of cases among MSM (men who have sex with men) in France between 2013 and 2015 [3], a 5% rise between 2013 and 2015 in the United States [4], and an increase of 29%–146% in almost all Australian states between 2010 and 2014 [5], all reflecting longer-term trends. Decreasing condom use [6], increased urbanization and travel, poor infection detection rates, and inadequate or failed treatment [7] all contribute to this increase.

Scroll to top

Send this to a friend